ASCO 2023: Memorial Sloan Kettering Cancer Center Experts to Present Leading Edge Research at the American Society of Clinical Oncology Annual Meeting

MSK researchers presenting new research at ASCO 2023, include Carol Aghajanian, MD; Ingo K. Mellinghoff, MD, FACP; and Deb Schrag, MD, MPH

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2–6 in Chicago. The event will feature plenary, oral abstract, education, and special sessions in both in-person and online meeting formats.

MSK experts will be available to comment on their high-profile research on topics such as brain cancer, ovarian cancer, rectal cancer, and more:

  • Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, will present significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.
  • Deb Schrag, MD, MPH, gastrointestinal oncologist and Chair of the Department of Medicine, will present results from a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total surgical excision for the treatment of patients with locally advanced rectal cancer.
  • Carol Aghajanian, MD, gynecologic oncologist and Chief of the Gynecologic Medical Oncology Service, will highlight results from a phase III trial that found that a maintenance therapy resulted in improved outcomes as a first-line treatment in patients with advanced ovarian cancer.

In addition, as part of the 2023 Annual Meeting, several MSK physician-scientists have been honored with prestigious awards by ASCO, including:

For more information and to set up interviews with MSK experts, contact John Connolly, Director of Media Relations, at [email protected]. Follow the meeting live on Twitter using the hashtag #ASCO23 and follow MSK on Twitter at @MSKCancerCenter.

Request an appointment